Skip to main content

Table 3 Median differences of estimated absorbed dose in normal tissues and bone metastases between 2D and 3D method, and between hybrid and 3D method

From: Comparison of different methods for post-therapeutic dosimetry in [177Lu]Lu-PSMA-617 radioligand therapy

  Median of differences
2D vs. 3D
Median of differences
HYBRID vs. 3D
[Gy/GBq] [%] p-value [Gy/GBq] [%] p-value
Parotid gland −0.080 −9.8 0.003 0.002 0.3 0.685
Submandibular gland −0.003 −0.4 0.950 0.014 1.9 0.440
Kidneys −0.059 −10.9 0.005 −0.021 −4.0 0.060
Liver −0.004 −3.5 0.093 0.003 2.9 0.100
Bone metastases −0.074 −4.4 <0.0001 −0.117 −7.0 <0.0001